Variables affecting darbepoetin resistance index in hemodialysis patients

Erythropoietin resistance index calculation has been used as a tool to evaluate anemia response to erythropoietin therapy. Very little has been reported in its use when using darbepoetin and factors influencing in Arab patients. Darbepoetin resistance index (DRI) was calculated in all our patients u...

Full description

Bibliographic Details
Main Authors: Fayez Hejaili, Ehtsham Hafeez, Burhan Bhutto, Lulwa Al Turki, Abdul Kareem Alsuwida, Hammad Raza, Abdulla Al-Sayyari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=4;spage=737;epage=742;aulast=Hejaili
id doaj-1af9d219356a437198ebce9869330d8c
record_format Article
spelling doaj-1af9d219356a437198ebce9869330d8c2020-11-24T23:05:52ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422017-01-01284737742Variables affecting darbepoetin resistance index in hemodialysis patientsFayez HejailiEhtsham HafeezBurhan BhuttoLulwa Al TurkiAbdul Kareem AlsuwidaHammad RazaAbdulla Al-SayyariErythropoietin resistance index calculation has been used as a tool to evaluate anemia response to erythropoietin therapy. Very little has been reported in its use when using darbepoetin and factors influencing in Arab patients. Darbepoetin resistance index (DRI) was calculated in all our patients using darbepoetin. This was correlated to demographic, clinical, and laboratory parameters. Of the 250 patients, 40.4% were diabetic, 71.1% on hemodialysis, and 28.6% on hemodiafiltration), 23.9% with PermCaths (PC), and 76.1 % with arteriovenous fistula (AVF). The mean DRI was 10.96 ± 12.9 I. Females had 45% higher DRI than males (P = 0.005), and patients with PC had a 66% higher DRI than those with AVF (P = 0.029). Patients with Vitamin D level below the 50th percentile had 55.9% higher DRI than those above it (P = 0.05). DRI was negatively correlated with age (P = 0.018), dialysis vintage (P = 0.039), interdialytic weight gain P = 0.007), Vitamin D level, and serum albumin (P = 0.005) and positively correlate with parathyroid hormone (PTH) level (P = 0.000). No impact was seen by the mode of dialysis, being diabetic, using anti-hypertensive therapy, body mass index, Kt/V, serum iron, total iron binding capacity, transferrin saturation, ferritin, C-reactive protein, Ca, or P. DRI in our Arab patients was comparable to erythropoietin resistance indices reported in other communities. Higher DRI was observed in females, PC users, lower serum albumin, lower Vitamin D, and shorter dialysis vintage. A negative correlation existed between DRI and age, dialysis vintage, interdialytic weight, and serum albumin and a positive correlation with PTH level.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=4;spage=737;epage=742;aulast=Hejaili
collection DOAJ
language English
format Article
sources DOAJ
author Fayez Hejaili
Ehtsham Hafeez
Burhan Bhutto
Lulwa Al Turki
Abdul Kareem Alsuwida
Hammad Raza
Abdulla Al-Sayyari
spellingShingle Fayez Hejaili
Ehtsham Hafeez
Burhan Bhutto
Lulwa Al Turki
Abdul Kareem Alsuwida
Hammad Raza
Abdulla Al-Sayyari
Variables affecting darbepoetin resistance index in hemodialysis patients
Saudi Journal of Kidney Diseases and Transplantation
author_facet Fayez Hejaili
Ehtsham Hafeez
Burhan Bhutto
Lulwa Al Turki
Abdul Kareem Alsuwida
Hammad Raza
Abdulla Al-Sayyari
author_sort Fayez Hejaili
title Variables affecting darbepoetin resistance index in hemodialysis patients
title_short Variables affecting darbepoetin resistance index in hemodialysis patients
title_full Variables affecting darbepoetin resistance index in hemodialysis patients
title_fullStr Variables affecting darbepoetin resistance index in hemodialysis patients
title_full_unstemmed Variables affecting darbepoetin resistance index in hemodialysis patients
title_sort variables affecting darbepoetin resistance index in hemodialysis patients
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2017-01-01
description Erythropoietin resistance index calculation has been used as a tool to evaluate anemia response to erythropoietin therapy. Very little has been reported in its use when using darbepoetin and factors influencing in Arab patients. Darbepoetin resistance index (DRI) was calculated in all our patients using darbepoetin. This was correlated to demographic, clinical, and laboratory parameters. Of the 250 patients, 40.4% were diabetic, 71.1% on hemodialysis, and 28.6% on hemodiafiltration), 23.9% with PermCaths (PC), and 76.1 % with arteriovenous fistula (AVF). The mean DRI was 10.96 ± 12.9 I. Females had 45% higher DRI than males (P = 0.005), and patients with PC had a 66% higher DRI than those with AVF (P = 0.029). Patients with Vitamin D level below the 50th percentile had 55.9% higher DRI than those above it (P = 0.05). DRI was negatively correlated with age (P = 0.018), dialysis vintage (P = 0.039), interdialytic weight gain P = 0.007), Vitamin D level, and serum albumin (P = 0.005) and positively correlate with parathyroid hormone (PTH) level (P = 0.000). No impact was seen by the mode of dialysis, being diabetic, using anti-hypertensive therapy, body mass index, Kt/V, serum iron, total iron binding capacity, transferrin saturation, ferritin, C-reactive protein, Ca, or P. DRI in our Arab patients was comparable to erythropoietin resistance indices reported in other communities. Higher DRI was observed in females, PC users, lower serum albumin, lower Vitamin D, and shorter dialysis vintage. A negative correlation existed between DRI and age, dialysis vintage, interdialytic weight, and serum albumin and a positive correlation with PTH level.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=4;spage=737;epage=742;aulast=Hejaili
work_keys_str_mv AT fayezhejaili variablesaffectingdarbepoetinresistanceindexinhemodialysispatients
AT ehtshamhafeez variablesaffectingdarbepoetinresistanceindexinhemodialysispatients
AT burhanbhutto variablesaffectingdarbepoetinresistanceindexinhemodialysispatients
AT lulwaalturki variablesaffectingdarbepoetinresistanceindexinhemodialysispatients
AT abdulkareemalsuwida variablesaffectingdarbepoetinresistanceindexinhemodialysispatients
AT hammadraza variablesaffectingdarbepoetinresistanceindexinhemodialysispatients
AT abdullaalsayyari variablesaffectingdarbepoetinresistanceindexinhemodialysispatients
_version_ 1725625280063602688